Dermoscopy of Small Basal Cell Carcinoma: Study of 100 Lesions 5 mm or Less in Diameter

Sánchez-Martín, Jesús; Vázquez‐López, Francisco; Pérez‐Oliva, Narciso; Argenziano, Giuseppe

doi:10.1111/j.1524-4725.2012.02358.x

Cited by 24 publications

(24 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 Dermoscopy of these diseases shows similarities in some aspects (Chart 1). 1,7-10 Definitive diagnosis is made by histological examination of the lesion. …”

Section: Discussionmentioning

confidence: 99%

Granuloma faciale: a rare disease from a dermoscopy perspective

Teixeira

Estrozi²,

Ianhez

2013

An. Bras. Dermatol.

View full text Add to dashboard Cite

The granuloma faciale is a rare and benign skin disease of unknown etiology, characterized by chronic leukocitoclastic vasculitis. It is characterized by skin lesions predominantly facial whose course is chronic and slowly progressive. The diagnosis is based on clinical features, histopathology and, more recently, in dermoscopy. We describe the case of a male patient, 40 years old, with a sarcoid lesion on the malar site, whose histopathological examination revealed a mixed inflammatory infiltrate with presence of Grenz zone. Dermoscopy revealed a pink background with white striations. The definitive diagnosis is made by histopathologic evaluation, and dermatoscopy can be helpful. It is known to be resistant to therapy, oral medications, intralesional and surgical procedures are options.

show abstract

“…1 Dermoscopy of these diseases shows similarities in some aspects (Chart 1). 1,7-10 Definitive diagnosis is made by histological examination of the lesion. …”

Section: Discussionmentioning

confidence: 99%

Granuloma faciale: a rare disease from a dermoscopy perspective

Teixeira

Estrozi²,

Ianhez

2013

An. Bras. Dermatol.

View full text Add to dashboard Cite

show abstract

“…Histopathologically, these structures corresponded to tumoral nests at the dermoepidermal junction. 8 Sanchez-Martin et al 5 studied dermoscopic features in BCC of 3 mm or smaller in diameter (n = 34) and those of 3.1-5 mm in diameter (n = 66). Forty-three lesions were non-pigmented or lightly pigmented, 46 were pigmented and 11 were heavily pigmented clinically.…”

Section: Discussionmentioning

confidence: 99%

Dermoscopic features of small size pigmented basal cell carcinomas

Takahashi

Hara

Aikawa

et al. 2015

The Journal of Dermatology

View full text Add to dashboard Cite

Dermoscopic images of histologically proven pigmented basal cell carcinomas (BCC) were retrospectively assessed to compare the dermoscopic features of BCC of 3 mm or less in diameter (n = 6) with BCC of 4-6 mm in diameter (n = 11). All lesions lacked the presence of a pigment network. BCC with a diameter of 3 mm or less had fewer positive dermoscopic features compared with the 4-6 mm in diameter BCC. Multiple blue-gray globules and large blue-gray ovoid nests were frequently present. Dermoscopy is a useful tool for early diagnosis of pigmented BCC, even when they are small.

show abstract

“…For example, while our diagnostic accuracy was >99%, we decided to use 80% from literature to better reflect the average dermatology practice. This number is expected to rise with the increasing using of imaging tools such as dermoscopy 15,17, 18 . In addition, we set the percent of shave removal applicability to 50% of non-MMS-indicated lesions factoring in presenting size <1cm and clinical judgment, but we anticipate this number to be higher as other studies on shave removal have set the size threshold at 1.5–2.5cm without compromising success rate 17,19 .…”

Section: Discussionmentioning

confidence: 99%

Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis

Elkin

Chen

et al. 2015

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Background Facing rising incidence of basal cell carcinoma (BCC) and increasing pressure to contain healthcare spending, physicians need to contemplate cost-effective paradigms for managing BCC. Objective To perform a cost analysis comparing the traditional BCC management scheme to a simplified Detect and Treat (DAT) scheme that eliminates the biopsy prior to initiating definitive treatment. Methods A decision analytic model was developed to compare the costs of traditional BCC management with the DAT scheme, under which qualifying lesions diagnosed clinically were either treated with shave removal or referred to Mohs for on-site histologic check. Values for model parameters were based on literature and our institutional data analysis. Costs were based on 2014 Medicare fee schedule. Results The average cost per lesion with DAT scheme was $449 for non-Mohs-indicated lesions (vs. $566 with traditional management, $117 in savings) and $819 for Mohs-indicated lesions (vs. $864 with traditional management, $45 in savings). The combined weighted average savings per case was $95 (15% of total average cost). Conclusions were similar under various plausible scenarios. Limitations Model parameter values may vary based on individual practices. Conclusions A simplified management strategy eliminating routine pre-treatment biopsy can reduce BCC treatment cost without compromising quality of care.

show abstract

Dermoscopy of Small Basal Cell Carcinoma: Study of 100 Lesions 5 mm or Less in Diameter

Cited by 24 publications

References 11 publications

Granuloma faciale: a rare disease from a dermoscopy perspective

Granuloma faciale: a rare disease from a dermoscopy perspective

Dermoscopic features of small size pigmented basal cell carcinomas

Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis

Contact Info

Product

Resources

About